Literature DB >> 15876756

Impact of availability of oral hydrocortisone on growth of children with CAH.

V V Khadilkar1, A V Khadilkar, G B Maskati.   

Abstract

OBJECTIVES: 1. To compare growth parameters of patients with Congenital Adrenal Hyperplasia (CAH) managed on Prednisolone (PR) before and on Hydrocortisone (HC) after its availability in India. 2. To compare growth parameters of patients with CAH who have been on treatment with HC since diagnosis with patients managed on PR.
METHODS: Growth parameters of twelve children (8 m, 4 f) with congenital adrenal hyperplasia were retrospectively studied while on treatment with prednisolone (PR) earlier and then hydrocortisone (HC) after it became freely available in India.
RESULTS: Patients treated with PR had height Z score of -0.42, weight Z score of - 0.45, and height velocity Z score of -2.06. On HC these scores were -0.27, +0.16 and + 2.27. Patients treated with HC from the begining had a height Z Score of + 0.08, weight Z score of +0.22, and height velocity Z score of +0.68.
CONCLUSION: Hydrocortisone has a less growth effect than prednisolone and patients treated with HC from the beginning showed near normal growth.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15876756     DOI: 10.1007/bf02724009

Source DB:  PubMed          Journal:  Indian J Pediatr        ISSN: 0019-5456            Impact factor:   1.967


  7 in total

1.  The effect of treatment of final height in classical congenital adrenal hyperplasia (CAH).

Authors:  J DiMartino-Nardi; E Stoner; A O'Connell; M I New
Journal:  Acta Endocrinol Suppl (Copenh)       Date:  1986

2.  Physical growth in Indian affluent children (birth-6 years).

Authors:  D K Agarwal; K N Agarwal
Journal:  Indian Pediatr       Date:  1994-04       Impact factor: 1.411

3.  Standards from birth to maturity for height, weight, height velocity, and weight velocity: British children, 1965. I.

Authors:  J M Tanner; R H Whitehouse; M Takaishi
Journal:  Arch Dis Child       Date:  1966-10       Impact factor: 3.791

4.  Prednisolone in the treatment of adrenal insufficiency: a re-evaluation of relative potency.

Authors:  Zubin Punthakee; Laurent Legault; Constantin Polychronakos
Journal:  J Pediatr       Date:  2003-09       Impact factor: 4.406

5.  Growth inhibition by glucocorticoid treatment in salt wasting 21-hydroxylase deficiency: in early infancy and (pre)puberty.

Authors:  Nike M M L Stikkelbroeck; Bep A E Van't Hof-Grootenboer; Ad R M M Hermus; Barto J Otten; Martin A Van't Hof
Journal:  J Clin Endocrinol Metab       Date:  2003-08       Impact factor: 5.958

Review 6.  Physical and sexual growth pattern of affluent Indian children from 5 to 18 years of age.

Authors:  D K Agarwal; K N Agarwal; S K Upadhyay; R Mittal; R Prakash; S Rai
Journal:  Indian Pediatr       Date:  1992-10       Impact factor: 1.411

7.  Auxological and biochemical parameters in assessing treatment of infants and toddlers with congenital adrenal hyperplasia due to 21-hydroxylase deficiency.

Authors:  S Einaudi; R Lala; A Corrias; P Matarazzo; S Pagliardini; C de Sanctis
Journal:  J Pediatr Endocrinol       Date:  1993 Apr-Jun
  7 in total
  2 in total

1.  Is hydrocortisone really better?

Authors:  John Mathew; K Sudeep
Journal:  Indian J Pediatr       Date:  2006-01       Impact factor: 1.967

2.  An Evidence-Based Model of Multidisciplinary Care for Patients and Families Affected by Classical Congenital Adrenal Hyperplasia due to 21-Hydroxylase Deficiency.

Authors:  Traci L Schaeffer; Jeanie B Tryggestad; Ashwini Mallappa; Adam E Hanna; Sowmya Krishnan; Steven D Chernausek; Laura J Chalmers; William G Reiner; Brad P Kropp; Amy B Wisniewski
Journal:  Int J Pediatr Endocrinol       Date:  2010-03-18
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.